It's Wednesday and we welcome you to another episode of our podcast! In this episode, we feature Henok Teka, the CEO and Co-founder of Droga Group.

Droga Group encompasses various companies, including pharmaceutical import, retail shops, farm product export, and other entities under the Droga Group umbrella. Henok is also the founder of Droga Pharma, a company providing healthcare solutions tailored to the evolving needs of healthcare facilities and organizations within the Ethiopian health sector.

In our conversation, Henok shares his entrepreneurial journey, detailing how he established his diverse portfolio of companies, the challenges he has faced, and his plans for the future.

Listen to how the Droga team's collaborative efforts and the importance of mutual trust and cooperation among partners have propelled them to succeed.

Join us to hear Henok Teka outline his vision to create 50,000 jobs by 2035.

Don't forget to subscribe to our channel for more insightful content, and share your thoughts in the comment section below!

0:00 - Intro
3:02- Who is Henok Teka
6:52 - Why Butajera School is the best
8:45 - Starting Business
16:25 - Droga
22:28 - Use of Participating in Global Expos for business
25:51 - Franchised pharmacies in Ethiopia
42:04-Right way of prescribing
49:14 - Expanding internationally
54:45 - Ambitious goals
57:12 - Vision , Ambition and its challenges
1:06:08 – Execution
1:10:58- Giving company share
1:15:48- Challenging times
1:25:02- Managing partnership
1:28:19 – Employee Retention
1:35:30 – Paying competitive
1:40:48 – Evaluating Performance
1:46:06 – Meeting with management
1:50:04- One wisdom


@Meriwoch @mericlipset

Social Links

https://t.me/MERI_PODCAST

  / meri_podcast  

  / meripodcast  

   / @meripodcast  
   / @meriwoch  
   / @mericlipset  

  / meripodcast  

  / meriethiopian  

Copyright Notice for Meri Podcast:

All rights reserved.

The content featured in this podcast is protected by copyright laws. Unauthorized reproduction, distribution, or modification of any portion of this podcast is strictly prohibited.

For permission to use our content, please contact us at [email protected]

Thank you for respecting our copyright.